Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Prevnar 13
Prevnar 13
Ready, set, pneumococcal vaccine: Pfizer teams up again with former football pro Terry Bradshaw
Ready, set, pneumococcal vaccine: Pfizer teams up again with former football pro Terry Bradshaw
Fierce Pharma
Pfizer
celebrity endorsements
vaccines
pneumococcal disease
Prevnar 13
Flag link:
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Merck snags priority review for Prevnar 13 rival — just one month after Pfizer sent its follow-on to the FDA
Endpoints
Merck
V114
pneumococcal disease
vaccines
FDA
priority review
Prevnar 13
Pfizer
Flag link:
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again
Fierce Biotech
Merck
Pfizer
vaccines
Prevnar 13
clinical trials
V114
pneumococcal disease
Flag link:
Merck’s pneumonia vaccine posts two more hits
Merck’s pneumonia vaccine posts two more hits
EP Vantage
Merck
vaccines
V114
Pfizer
Prevnar 13
Flag link:
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Homegrown rivals to Pfizer, Merck cash cow vaccines win nods in China
Fierce Pharma
Pfizer
Merck
Prevnar 13
Gardasil
vaccines
China
Walvax
Flag link:
Pfizer touts successor to Prevnar 13
Pfizer touts successor to Prevnar 13
Biopharma Dive
Pfizer
Prevnar 13
vaccines
clinical trial
pneumococcal disease
Flag link:
U.S. advisory panel stops short of broad recommendations for two common vaccines
U.S. advisory panel stops short of broad recommendations for two common vaccines
Stat
FDA
vaccines
HPV
pneumonia
advisory panels
Merck
Gardasil
Pfizer
Prevnar 13
Flag link:
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Looking to topple Pfizer's Prevnar 13 dynasty, Merck claims another win for its 'breakthrough' pneumococcal conjugate vaccine
Endpoints
Merck
Pfizer
vaccines
pneumococcal disease
V114
Prevnar 13
FDA
Flag link:
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
FDA blesses Merck’s PhIII effort to topple a mega-blockbuster — but there’s also a little biotech in this game
Endpoints
Merck
V114
vaccines
FDA
breakthrough status
Prevnar 13
Pfizer
Flag link:
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Merck pits its pneumococcal shot against Pfizer's mammoth Prevnar in head-to-head ph3
Fierce Pharma
Merck
pneumococcal disease
V114
Pfizer
Prevnar 13
Flag link:
Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way
Don't sweat Prevnar's problems, Pfizer R&D chief says. New vaccines are on their way
Fierce Pharma
Pfizer
R&D
Prevnar 13
vaccines
Flag link:
Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180
Pfizer's Prevnar 13 set for another price hike in 2018 as U.S. price-per-dose climbs near $180
Fierce Pharma
Pfizer
Prevnar 13
vaccines
drug pricing
Flag link:
Pneumonia vaccine triples protection in animal models
Pneumonia vaccine triples protection in animal models
Fierce Biotech
vaccines
pneumonia
antibiotic resistance
Merck
Pneumovax 23
Pfizer
Prevnar 13
Flag link:
Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates
Prevnar 13 among blockbusters industry watchers peg as tribal licensing candidates
Fierce Pharma
Prevnar 13
vaccines
licensing
Pfizer
Flag link:
Top 25 vaccine products in 2016, based on U.S. sales
Top 25 vaccine products in 2016, based on U.S. sales
Medical Marketing and Media
vaccines
Pfizer
Merck
Sanofi
Prevnar 13
Gardasil
Fluzone
Varivax
Menactra
Flag link:
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
Pfizer Wins Indian Patent on Prevnar 13 Vaccine
RAPS.org
Pfizer
India
Prevnar 13
vaccine
patents
Flag link:
SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines
SutroVax raises $64M with plans to challenge Pfizer’s megablockbuster Prevnar 13 for the heavyweight title in vaccines
Endpoints
SutroVax
Pfizer
vaccines
pneumococcal disease
Prevnar 13
Flag link:
Pfizer Has Strong Track Record since 2010
Pfizer Has Strong Track Record since 2010
Market Realist
Pfizer
drug approvals
Ibrance
Prevnar 13
Inlyta
Xalkori
Xeljanz
Flag link:
Pfizer offers cut-price pneumonia shot for humanitarian crises
Pfizer offers cut-price pneumonia shot for humanitarian crises
Yahoo/Reuters
Pfizer
pneumonia
vaccines
Prevnar 13
GSK
Flag link:
Interesting Trend Developing for Pfizer’s Pneumococcal Franchise
Interesting Trend Developing for Pfizer’s Pneumococcal Franchise
Market Realist
Pfizer
vaccines
Prevnar 13
pneumococcal disease
Flag link:
Pages
1
2
3
next ›
last »